CID 135415944

Mntde-2-imp5+

Structural Information

Molecular Formula
C48H58N12
SMILES
CCN1C=C[N+](=C1C2=C3C=CC(=C(C4=NC(=C(C5=CC=C(N5)C(=C6C=CC2=N6)C7=[N+](C=CN7CC)CC)C8=[N+](C=CN8CC)CC)C=C4)C9=[N+](C=CN9CC)CC)N3)CC
InChI
InChI=1S/C48H57N12/c1-9-53-25-26-54(10-2)45(53)41-33-17-19-35(49-33)42(46-55(11-3)27-28-56(46)12-4)37-21-23-39(51-37)44(48-59(15-7)31-32-60(48)16-8)40-24-22-38(52-40)43(36-20-18-34(41)50-36)47-57(13-5)29-30-58(47)14-6/h17-32H,9-16H2,1-8H3,(H,49,50,51,52)/q+3/p+1
InChIKey
BLFRNAAIGZNDLM-UHFFFAOYSA-O
Compound name
5,10,15,20-tetrakis(1,3-diethylimidazol-1-ium-2-yl)-21,23-dihydroporphyrin
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

32
Patents

802.4907 Da
Monoisotopic Mass

5.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 803.49798 231.2
[M+Na]+ 825.47992 235.1
[M-H]- 801.48342 243.3
[M+NH4]+ 820.52452 229.6
[M+K]+ 841.45386 220.0
[M+H-H2O]+ 785.48796 235.4
[M+HCOO]- 847.48890 238.9
[M+CH3COO]- 861.50455 258.5
[M+Na-2H]- 823.46537 242.4
[M]+ 802.49015 240.8
[M]- 802.49125 240.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe